| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 |
| Total Revenue | 240 | 258 | 200 | 910 |
| Cost of Revenue | 90 | 108 | 103 | 284 |
|
| Gross Profit | 149 | 150 | 98 | 625 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative | 288 | 290 | 283 | 646 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (139) | (140) | (186) | (20) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
-
| (0) | (10) |
| Earnings Before Interest And Taxes | (139) | (140) | (186) | (31) |
| Interest Expense |
-
|
-
|
-
|
-
|
| Income Before Tax | (139) | (140) | (186) | (31) |
| Income Tax Expense | 0 | 0 | 4 |
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (139) | (140) | (190) | (31) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (139) | (140) | (190) | (31) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($139) | ($140) | ($190) | ($31) |
0.51% Nasdaq 
Income Statement
